Inflammatory skin disease including the use of biologics and complex systemic therapies – Our specialists have years of experience with the leading FDA approved biologics, including but not limited to:
- Adalimumab
- Brodalumab
- Ixekizumab
- Etanercept
- Guselkumab
- Secukinumab
- Rizankizumab
- Dupilumab
If a new biologic is not right for you, we can offer you a variety of systemic therapies for your skin disease including but not limited to methotrexate, mycophenolate, cyclosporine, soriatane, and azathioprine.
In addition, our experts are continually engaged in clinical trials to find the latest and greatest topical and systemic therapies for skin disease, so by being under their watchful care, you are at the leading edge of medical advances.